Company intelligence / Profile preview

SL Strategies

Ownership: Private
Development stage: Other

Overview

SL Strategies is a strategy consulting and lobbying firm specializing in the intersection of science, law, and public policy to improve health outcomes. The firm advises clients in life sciences, healthcare workforce organizations, nonprofits, and other sectors impacting human health. It is known for its expertise in bioethics and coalition-building to drive better policy decisions. The company does not conduct clinical research or have therapeutic programs. In 2025 it was retained by multiple major pharmaceutical/biotech companies for federal lobbying services.

Industry: Consulting

Partnerships

A19 StrategiesLKB StrategiesHither Creek Strategies

Beyond the preview

Go deeper on SL Strategies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SL Strategies.

Explore the full profile